Heterogeneity of immune infiltration and immunotherapy in colorectal cancer  

作　　者：Yichen Li Jun Hu Min Zhi 

机构地区：[1]School of Medicine,Jiaying University,Meizhou,Guangdong,P.R.China [2]Zhongshan School of Medicine,Sun Yat-sen University,Guangzhou,Guangdong,P.R.China [3]Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease,The Sixth Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong,P.R.China [4]Department of Gastroenterology,The Sixth Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong,P.R.China

出　　处：《Gastroenterology Report》2024年第1期860-861,共2页胃肠病学报道(英文)

基　　金：supported by the Sun Yat-sen University Clinical Research 5010 Program[2014008];the National Natural Science Foundation of China[82270544(M.Z.)]and[81600419(J.H.)];the program of Guangdong Provincial Clinical Research Center for Digestive Diseases[2020B1111170004].

摘　　要：Wu et al.[1]recently published a study on potential prognostic and therapeutic values of immune cell infiltration(ICI)subtypes in colorectal cancer(CRC).In this study,they creatively designed a new approach combining the CIBERSORT and ESTIMATE methods to assess the differences in the intra-tumor immune infiltration landscape of CRC samples and its association with prognosis.

关 键 词：prognosis COLORECTAL 

分 类 号：R730.5[医药卫生—肿瘤]